Flexible Data Collection and Best DCT Strategies: Advice from an Expert

About the Episode:

As the COVID-19 pandemic encourages the widespread adoption of decentralized clinical trial models, there are opportunities to optimize existing processes to make clinical research easier for sites and sponsors to conduct, and for patients to participate. Jonathan Andrus, Clinical Ink, discusses his advice as a flexible data collection expert, thoughts on wider adoption of DCTs and where he thinks the future is headed.
 

Key Takeaways:

• The role of regulatory guidance, how-to's and industry examples
• Shifting from a "surviving" to "thriving" mentality in regards to DCTs
• Next steps for the industry

About the Speaker:

Jonathan Andrus is Chief Strategy Officer of Clinical Ink. He is responsible for driving the corporate strategic vision, communicating the plan with all those involved, executing the business initiatives, and sustaining implementation efforts. This includes driving important internal initiatives, identifying potential targets for acquisition, and other partnership opportunities to help drive the business forward.

About Mobile in Clinical Trials:

Mobile in Clinical Trials is the meeting place for digital R&D operations leaders who are seeking solutions to apply mobile-digital tools into clinical research.  Each year, we bring forward the latest experience-based case studies while presenting fresh ideas to advance fit for purpose, adoption and scale of remote digital solutions. For more information, click here.

For more information about PharmaTalk Radio, visit theconferenceforum.org.